INCR / InterCure To Acquire Israel-Based Medical Cannabis Producer Better For $35M

InterCure Ltd. (NASDAQ:INCR ) Q4 2022 Earnings Conference Call April 4, 2023 4:30 PM ET Company Participants Alexander Rabinovitch - CEO & Director Am more_horizontal

NEW YORK, TORONTO, and HERZLIYA, Israel, April 03, 2023 (GLOBE NEWSWIRE) -- InterCure Ltd . (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc)("I more_horizontal

InterCure earned CAD$39 million in Q3 2022, up 61.2% from the previous year. Moreover, at the end of Q4 2022, the total number of licensed patients us more_horizontal

Legal cannabis around the world is just beginning but will surpass that of North America. Europe is one of the largest growth markets for companies in more_horizontal

The global cannabis market will eventually be far bigger than North America. InterCure is a leading company in global pharmaceutical cannabis. more_horizontal

InterCure Ltd. (NASDAQ:INCR ) Q1 2022 Earnings Conference Call May 17, 2022 8:00 AM ET Company Participants Adam Haliva - Communications Officer Alex more_horizontal

Conference call scheduled for Tuesday, May 17, 2022, at 8:00am ET Conference call scheduled for Tuesday, May 17, 2022, at 8:00am ET more_horizontal

Will release financial results for the fourth quarter of 2021 before market open on Monday, April 4, 2022 more_horizontal